Cornerstone Pharmaceuticals-B (02616): ACAAI 2025 | CS2015 (OX40L/TSLP bispecific antibody) makes its first appearance on the international academic stage.

Zhixun Finance APP News, Cornerstone Pharmaceuticals-B (02616) announced that the company will exhibit one of its pipeline products, CS2015 (OX40L/TSLP bispecific antibody), in the form of "electronic poster + on-site oral presentation" at the American College of Allergy, Asthma, and Immunology (ACAAI) Annual Scientific Meeting in 2025. ACAAI is one of the most influential academic conferences in the field of allergy, asthma, and immunology worldwide, attracting numerous experts and scholars from around the world to discuss the latest research findings. This will be the first international appearance of CS2015 at an academic conference, and the full content of the abstract and electronic poster is now officially available on the ACAAI website.